At Lone Star Centers, patients work directly with expert weight loss provider Brenda Johnson to access safe, effective therapies, including Ozempic, as part of a comprehensive health plan
From gastrointestinal discomfort to gallbladder risks and pancreatitis concerns, this article explores what we know, what we dont, and how to counsel patients realistically about long-term therapy
Together, these actions create a metabolic environment that supports steady, clinically meaningful weight loss
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): A substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
This article explores how GLP-1 medications affect blood pressure, identifies risk factors for hypotension, and provides practical management strategies to optimize treatment outcomes